Building Clinical Decision Support: Architecture Patterns for Safe, Scalable CDSS
healthtecharchitectureai

Building Clinical Decision Support: Architecture Patterns for Safe, Scalable CDSS

DDaniel Mercer
2026-04-11
24 min read
Advertisement

A deep-dive CDSS architecture guide on FHIR, model serving, audit trails, edge-cloud tradeoffs, and safe scaling.

Building Clinical Decision Support: Architecture Patterns for Safe, Scalable CDSS

Clinical decision support is moving from niche hospital IT to a high-growth engineering category, and the signal is clear: the market is expanding quickly, integration expectations are getting stricter, and teams entering healthtech need architectures that are safe from day one. Recent market coverage projects the clinical decision support systems market to grow at a CAGR of 10.89%, underscoring why product teams, platform engineers, and healthcare IT leaders are treating CDSS as a long-term infrastructure problem rather than a feature add-on. If your team is building for real clinical environments, the challenge is not just model quality; it is also clinical workflow ROI, EHR interoperability, security, governance, and auditability across every recommendation path. In practice, that means designing for integration first, because a brilliant model that cannot safely fit into existing user workflows or withstand compliance review will not survive procurement.

This guide breaks down the core architecture patterns engineering teams need to evaluate: model-serving topologies, FHIR-based integration, audit trails, edge versus cloud inference, resilience patterns, and privacy controls. It also shows how to think about CDSS as part of a broader systems problem, similar to how teams building safer AI agents for security workflows must combine automation with guardrails. The goal is to give you a deployment-minded blueprint for building a CDSS that can scale safely, operate under clinical scrutiny, and plug into messy healthcare environments without creating new operational debt.

1) What CDSS Actually Needs to Do in Production

Support decisions, not replace judgment

A production CDSS should help clinicians make better decisions faster, not attempt to be an autonomous authority. That distinction matters because safety requirements change dramatically when software is advisory versus directive. In most real deployments, the system ingests patient context, evaluates clinical rules or machine learning outputs, and returns recommendations with rationale, confidence, and provenance. Engineering teams often underestimate how much explanation and traceability matter until a clinical stakeholder asks, “Why did the system suggest this?”

Good CDSS design treats the recommendation engine as one component in a larger decision pipeline. Input normalization, identity matching, context resolution, rule evaluation, model inference, alert ranking, and logging must all be designed explicitly. This is the same kind of operational discipline seen in faster market intelligence systems, where output quality depends on the entire data path, not just the final analytics layer. For healthtech teams, this means prioritizing observability, deterministic fallbacks, and human review paths.

Map the safety-critical failure modes early

Before choosing frameworks or cloud services, enumerate the failure modes: wrong patient context, stale data, duplicate alerts, missing allergies, latency spikes, partial EHR outages, and model drift. A clinical environment is unforgiving because even small integration errors can amplify into unsafe workflows. The engineering conversation must therefore include safety cases, not just uptime targets. Consider how teams working on regulated systems such as compliant self-driving models build evidence around edge cases, testing, and fallback behavior; CDSS requires the same rigor.

In practice, you should define what the system must never do, what it may suggest only with explicit verification, and what it can automate without clinician intervention. A safe architecture uses rule-based gating for high-risk actions, model outputs for ranking or prioritization, and policy engines for enforcement. This layered design reduces the probability that a single model error becomes a clinical incident. It also gives your compliance and security teams a concrete framework for review.

Design for heterogeneous sites from the start

Hospital systems, outpatient clinics, and specialty practices do not share the same infrastructure maturity. Some have modern EHR APIs and event buses; others still require HL7 interfaces, flat files, or vendor-specific integration points. Your CDSS must tolerate this heterogeneity without turning every deployment into a custom project. That is why architecture patterns should assume variation in data quality, latency tolerance, and authentication capability.

Teams used to clean SaaS onboarding often discover that healthcare integration resembles a mix of legacy migration and compliance engineering. If you have ever built around an operations crisis recovery playbook, you know that resilient systems are not the ones that never fail; they are the ones that keep operating safely when dependencies degrade. The same mindset applies to clinical support systems, where graceful degradation is a feature, not a bonus.

2) Reference Architecture for Safe, Scalable CDSS

The core layers: data, decision, delivery

A practical CDSS reference architecture usually has three main layers. The data layer handles patient context, encounter state, medications, problems, labs, and notes, ideally normalized through standards such as FHIR. The decision layer contains rules engines, ML inference services, scoring pipelines, and policy checks. The delivery layer renders recommendations into the EHR, clinician portal, mobile app, or background workflow. Keeping these layers separate reduces coupling and makes it easier to validate each component independently.

This separation also improves upgradeability. You can swap model-serving frameworks, change thresholds, or add new guidance without rebuilding the entire product. It is similar in spirit to how teams modernize thick-client software without rewriting every code path at once, as discussed in modernization paths for thick clients. In healthtech, incremental modernization is usually the only realistic path.

Event-driven architecture versus synchronous request/response

Most teams start with synchronous APIs because they are straightforward, but clinical use cases often benefit from event-driven patterns. For example, a lab result event can trigger post-processing, risk scoring, and notification generation without forcing the clinician workflow to wait. Event-driven designs also make it easier to support asynchronous audits, alert buffering, and downstream analytics. The challenge is ensuring that event ordering, deduplication, and idempotency are implemented rigorously.

For low-latency bedside assistance, synchronous model serving may still be the right choice. For population health, retrospective risk detection, and patient outreach, queued or streamed inference is often better. Many successful systems use a hybrid pattern: synchronous calls for interactive use and event pipelines for enrichment and background surveillance. The key is to align architecture with clinical timing requirements, not technical preference.

Deployment topologies that actually work

CDSS deployment generally falls into one of four patterns: embedded in the EHR, sidecar service, centralized platform, or federated multi-tenant service. Embedded tools maximize workflow proximity but are often constrained by vendor capabilities. Sidecar services are a common compromise because they keep the decision engine adjacent to clinical apps while preserving modularity. Centralized platforms simplify governance and analytics, but they can introduce latency and integration complexity across sites.

For organizations with varied facilities, a federated model can be effective: shared decision logic, site-specific configuration, and tenant-aware data boundaries. This approach is especially useful when teams need to adapt to different privacy or residency rules. If your organization is also building other connected systems, lessons from secure data aggregation and visualization transfer well: normalize inputs, centralize governance, and localize sensitive operations where necessary.

3) FHIR Integration and EHR Connectivity

Why FHIR is the center of modern CDSS integration

FHIR has become the most important interoperability layer for modern healthtech because it offers resource-oriented access to clinical data, standard semantics, and a growing ecosystem of implementation support. For CDSS, FHIR is valuable not because it eliminates complexity, but because it creates a consistent contract for patient, encounter, observation, medication, and condition data. That consistency makes it easier to build reusable integration modules and reduce custom parsing logic. It also makes auditability and testing more tractable.

A well-designed FHIR integration layer should treat resources as versioned contracts. Every resource type should be validated, transformed, and logged before it reaches the decision engine. This matters because small inconsistencies in coding systems, units, or missing values can drastically change a clinical recommendation. Engineering teams entering the space should treat FHIR schema drift as a first-class operational risk, not an edge case.

Handle EHR limitations without breaking the product

Real-world EHR integration is rarely as clean as the standards docs suggest. Some systems expose limited APIs, rate limit aggressively, or require proprietary event subscriptions. Others have different data freshness expectations or require pre-authenticated workflow contexts. Your integration layer needs adapters, retries, caching, and fallback modes to survive these constraints. This is why vendor abstraction is so important in CDSS architecture.

When building connectors, isolate provider-specific logic behind an integration service and keep your clinical rules and model layers independent. That way, if an EHR vendor changes its API or a hospital changes authentication policy, you can fix the connector without revalidating the whole system. Similar to how teams managing digital operations should understand the operational checklist behind selecting a 3PL provider, healthcare integrations require contract discipline, clear SLAs, and explicit responsibility boundaries.

Data mapping, coding systems, and normalization

FHIR transport alone does not solve semantics. You still need robust mapping for ICD, SNOMED CT, LOINC, RxNorm, and local codes. The CDSS decision engine should consume canonical internal representations, not raw source-system strings. That means building a normalization pipeline that handles unit conversion, code translation, and confidence scoring for ambiguous mappings. Without it, recommendation quality will vary across sites in ways that are hard to detect.

Testing should include synthetic patient records, edge-case codes, and mixed-encoding scenarios. It should also include downstream validation for alert thresholds and rule hits. This is where teams benefit from the kind of data-centric rigor seen in data analysis case studies: the reliability of the output is only as good as the quality and consistency of the inputs.

4) Model Serving Patterns for Clinical Reliability

Rules-first, model-assisted, or hybrid?

Clinical decision support does not have to be purely rules-based or purely machine learning-based. In many real systems, the safest architecture is hybrid: rules enforce hard safety constraints, while models rank, prioritize, or contextualize suggestions. Rules excel when the clinical policy is explicit and stable, such as contraindications or required checks. Models are better for complex pattern recognition, risk scoring, or personalized ranking when the input space is large and dynamic.

A rules-first approach is often easier to validate and explain, which can accelerate early adoption. A model-assisted approach is useful when teams want better sensitivity without surrendering control. In high-risk workflows, the model should rarely be the final authority. It should instead provide a signal that is interpreted through policy, thresholds, and human oversight.

Online inference, batch scoring, and cached decisions

Model serving architecture should be chosen by clinical timing and operational risk. Online inference is appropriate when a clinician is actively reviewing a patient and needs a response in seconds. Batch scoring is often better for nightly risk stratification, outreach lists, or panel management. Cached decisions can dramatically reduce latency for repeated queries, but only if cache invalidation is tied to a patient context change such as new labs, medications, or encounter updates.

Be careful not to overuse real-time inference for use cases that do not need it. In healthcare, latency targets should be tied to user value, not engineering ambition. Teams that build resilient pipelines in other domains, such as real-time communication apps, know that real-time delivery is only useful when the downstream user truly needs immediate action. CDSS should follow the same discipline.

Versioning, rollback, and validation of model outputs

Every model in production should be versioned alongside its feature definitions, thresholds, and training data lineage. You need deterministic rollback because a model change that looks statistically better can still be clinically worse in a specific population. Release strategies should include canaries, shadow mode, and site-by-site validation before broader rollout. A model that cannot be safely rolled back is not production-ready for clinical use.

Model validation should include not only AUC or precision-recall, but also calibration, subgroup performance, and alert burden. Clinical teams care about how often the system fires, how many alerts are dismissed, and whether it changes outcomes in the intended population. For operational teams, this is where the engineering resembles writing release notes developers actually read: versioning must be visible, auditable, and meaningful to the people operating the system.

5) Audit Logging, Traceability, and Explainability

What must be logged for clinical defensibility

Audit logging is not optional in CDSS. You need a tamper-evident trail of input data, decision timestamps, rule hits, model version, explanation payloads, user identity, and final action taken. This trail is essential for compliance, incident investigation, and clinical review. It also helps you distinguish model defects from integration defects when something goes wrong.

At minimum, your logs should answer four questions: what data was used, what logic executed, what recommendation was returned, and who saw or acted on it. Logs should be structured, immutable, and queryable. Avoid ad hoc text logging for safety-critical pathways because it is hard to search, easy to corrupt, and nearly impossible to validate consistently.

Explainability that clinicians will actually trust

Clinicians do not need a machine learning tutorial; they need concise, relevant justification. Explainability should present the top factors, the clinical rule invoked, and the provenance of the evidence, not a confusing dump of probabilities. If possible, show the reason for the recommendation in the context of the patient state and current encounter. Transparency should reduce cognitive load, not increase it.

One useful design pattern is to separate machine explanation from clinical explanation. The machine explanation is for validators and engineers, while the clinical explanation is tailored to the workflow. This mirrors the differentiation seen in quality management platforms for identity operations, where operational evidence, audit workflows, and user-facing controls must serve different stakeholders without conflating their needs.

Audit trails as a product feature, not just compliance overhead

Auditability can be a competitive advantage because health systems increasingly ask for evidence, not promises. If your product can show why an alert fired, who reviewed it, and how it affected the workflow, you reduce adoption friction. Good audit trails also make post-market surveillance and safety review more efficient. In that sense, logging is part of the user experience for clinical operations teams.

Pro Tip: Treat audit logs like a clinical memory layer. If a recommendation cannot be reconstructed later, it cannot be defended, improved, or safely scaled.

6) Privacy, Security, and Access Control in Healthtech

Minimum viable privacy architecture

Healthtech privacy starts with data minimization. Only fetch the patient context necessary for the decision, and avoid broad data pulls when a narrower query will do. Tokenize or pseudonymize identifiers where feasible, and keep clinical identity resolution separate from analytics storage. Segregation reduces blast radius if a downstream service is compromised.

Access control should be role-based, attribute-based, and context-aware. A clinician, analyst, support engineer, and integration service should not have the same permissions. Because healthcare organizations often have complex trust boundaries, identity strategy must be designed as part of the platform architecture, not bolted on later. If you need a model for structured identity governance, the operational lessons in compliance management translate surprisingly well: permissions, documentation, and evidence all matter.

Encryption, secrets, and segmentation

Protect data in transit and at rest using modern encryption standards, and ensure secret rotation is operationally feasible. Separate environments for development, staging, validation, and production must have clear data handling rules, especially when clinical data is involved. Network segmentation should isolate the model-serving tier from user-facing interfaces and from long-term analytics stores. These boundaries reduce the risk that one compromised service can expose broad patient data.

You should also plan for audit-ready key management and incident response. In healthtech, security review is not just about preventing breaches; it is about proving control. When teams have already practiced recovery flows in other domains, such as secure file transfer operations, they are better prepared to document responsibilities and respond quickly to incidents.

Different clinical workflows have different consent and retention requirements. Your platform should support configurable retention policies, region-aware storage, and the ability to honor organizational rules around patient data use. If you expect international expansion, plan for residency constraints early, because retrofitting them into a monolithic architecture is expensive and risky. A federated data strategy often makes more sense than trying to force one global storage model.

Also consider secondary use: analytics, model retraining, and population health reporting often have different rules than point-of-care decision support. Separate these pipelines clearly and document what data is eligible for each purpose. That boundary is one of the clearest indicators of whether a healthtech team understands the difference between product telemetry and regulated clinical data.

7) Edge vs Cloud Inference: How to Choose

When edge inference makes sense

Edge inference is useful when latency, connectivity, or local autonomy matter. Examples include bedside devices, mobile care settings, rural clinics with intermittent connectivity, and scenarios where a recommendation must be available even during EHR downtime. Edge can also reduce bandwidth usage and limit centralized exposure of sensitive data. But edge adds complexity in device management, model distribution, and update coordination.

Edge deployment works best when the model is lightweight, the update cadence is manageable, and the clinical context is local. It is especially effective as a fallback or pre-screening layer. However, edge should not become an excuse to skip governance. You still need version control, telemetry, and strict rollback procedures.

When cloud inference is the better choice

Cloud inference is usually the default for teams that need elastic scaling, centralized monitoring, and simpler iteration. It makes it easier to run larger models, maintain a single validation pipeline, and integrate with shared logging and analytics. Cloud is particularly strong when the CDSS depends on multiple upstream services, frequent model updates, or cross-site consistency. For many organizations, the cloud becomes the authoritative brain while edge components provide local resilience.

Cloud, however, introduces network dependency and potential latency variation. If the recommendation is time-sensitive, you need caching, timeouts, and fail-open or fail-safe behavior defined in advance. Teams used to evaluating infrastructure tradeoffs, such as those comparing price-performance alternatives, know that the “best” option depends on workload constraints, not just raw capability.

Hybrid inference patterns for healthcare

The most practical answer is often hybrid. Run a small, deterministic edge layer for offline safety checks or pre-filtering, and send richer context to cloud services for deeper analysis. This enables both continuity and sophistication. If the cloud is unavailable, the edge layer can still perform basic checks and protect against dangerous omissions.

Hybrid models also support staged rollout. You can validate cloud recommendations in shadow mode, compare them to edge outputs, and gradually shift trust as confidence increases. This is especially important for enterprises adopting healthtech across geographically distributed sites where infrastructure and workflow maturity vary widely.

8) Scalability Patterns That Keep CDSS Stable Under Load

Queueing, backpressure, and rate limiting

Scalability in CDSS is less about peak throughput and more about predictable behavior during surges. Hospital systems can generate bursts of activity during shift changes, seasonal illness spikes, or EHR replay events. Your architecture should include queues, retries, circuit breakers, and backpressure so that overload does not produce unsafe or duplicate recommendations. If a downstream service is slow, the system should degrade predictably instead of cascading failure into the clinical workflow.

Rate limiting matters both internally and externally. An integration error or misconfigured client should not be able to flood the model-serving tier. The same principle applies in other high-volume environments, where transaction pacing and queue discipline are essential, much like in faster fulfillment operating models. In CDSS, throughput is important, but safe throughput is more important.

Horizontal scaling without losing determinism

Stateless services are easier to scale horizontally, but CDSS often relies on stateful context. The trick is to externalize state into well-designed stores with consistent lookup semantics while keeping inference workers stateless. Feature stores, configuration services, and patient context caches can all support this pattern. You gain elasticity without sacrificing reproducibility.

Make sure that repeated requests for the same patient context produce the same recommendation unless the underlying data has changed. Determinism is critical for trust and debugging. If two clinicians see different recommendations for the same state, your system will lose credibility quickly.

Observability metrics that matter in production

Standard service metrics such as CPU and error rate are not enough. You also need clinical metrics: recommendation volume, alert acceptance rate, override rate, stale-context hits, data-fetch latency, and recommendation turnaround time. Alert fatigue is a real operational threat, so monitoring should include whether a rule is too noisy before users stop trusting it. A useful monitoring stack tracks both technical health and clinical behavior.

Well-run systems use these metrics to tune thresholds and reduce noise. That mindset is similar to how teams optimize customer-facing systems in other domains, such as pricing models based on operational analytics. In CDSS, the ultimate optimization target is not revenue per request; it is clinically useful, safe intervention at scale.

9) Implementation Blueprint: From Pilot to Production

Phase 1: narrow use case, strict guardrails

Start with one narrow clinical use case that has measurable value and manageable risk, such as drug interaction checks, overdue screening reminders, or guideline-based alerts. Build hard guardrails before adding intelligence. Establish your integration contract, logging schema, and evaluation rubric early. This phase is about proving that the architecture can support safe recommendations in a real workflow, not about maximizing model sophistication.

Choose a pilot site that has both a clinical champion and operational support. Your first deployment should be instrumented heavily so you can observe usage, latency, overrides, and error patterns. This is also the right time to define governance, incident review procedures, and a model change policy.

Phase 2: reusable platform services

Once the pilot stabilizes, extract reusable platform components: patient context service, FHIR adapter, policy engine, model registry, and audit ledger. Treat these as shared products inside your company, not one-off project code. This makes it much easier to onboard new clinical use cases and new customer sites. It also prevents each feature team from reinventing basic safety infrastructure.

Teams that have experience with structured operational content, such as workflow digitization platforms, often move faster here because they understand process abstraction. In healthtech, the same abstraction discipline can turn a bespoke pilot into a scalable platform.

Phase 3: governance, retraining, and expansion

At scale, the hardest problems are governance and change management. You need policies for retraining, validation, approval, emergency rollback, and customer-specific configuration. Build a release process that ties every model version to a validation artifact and an accountable approver. This is not bureaucratic overhead; it is what makes the platform trustworthy enough for broader adoption.

Expansion should be measured site by site, use case by use case. New deployments should begin in shadow mode or low-risk advisory mode before becoming fully operational. If you do this well, the platform becomes easier to sell and easier to support, because the evidence for safety and value accumulates with each implementation.

10) Common Mistakes and How to Avoid Them

Overfitting the architecture to the first customer

Many early CDSS projects become fragile because they are over-customized for one hospital’s workflows or one clinician group’s preferences. That can create a short-term win but long-term maintenance pain. Instead, aim for configuration-driven behavior and modular connectors. A reusable platform will almost always outperform a custom one once you reach multiple customers or sites.

Another common mistake is shipping model outputs without a clear operational owner. If no one is accountable for threshold tuning, alert fatigue will creep in. The best teams define ownership across engineering, clinical, and compliance stakeholders from the beginning.

Confusing data integration with clinical intelligence

Bringing in FHIR data does not automatically create useful decision support. Integration is necessary but not sufficient. The system still needs clinical logic, trust calibration, human workflow fit, and operational safeguards. If your recommendation engine is strong but your data model is weak, the output will still be unreliable. Conversely, excellent data plumbing with no meaningful decision layer is just expensive plumbing.

Ignoring user trust and change management

Adoption fails when the system feels noisy, opaque, or disruptive. Clinicians need to understand why a recommendation matters and how to act on it quickly. This is why feedback loops are essential: let users report false positives, suppressed alerts, and usability issues. The product should improve over time based on actual clinical behavior, not just vendor assumptions.

Pro Tip: If the first version of your CDSS cannot explain itself in one sentence to a busy clinician, it is not ready for the bedside.

11) Architecture Comparison: Choosing the Right CDSS Pattern

The table below compares the most common CDSS architecture patterns and the tradeoffs engineering teams should expect when moving into healthtech.

PatternBest ForStrengthsTradeoffsTypical Risk Level
Rules-only engineGuideline checks, contraindicationsHighly explainable, easy to validateLimited adaptability, manual maintenanceLow
ML-assisted CDSSRisk ranking, prioritizationAdaptive, can capture complex patternsRequires governance, calibration, drift monitoringMedium
FHIR-integrated sidecarEHR-connected point-of-care supportModular, easier to deploy across systemsConnector complexity, vendor variabilityMedium
Centralized cloud CDSSMulti-site enterprise platformsUnified monitoring, fast iteration, scalableNetwork dependency, privacy and residency concernsMedium to High
Hybrid edge-cloud CDSSOffline resilience, distributed careLow-latency fallback, flexible deploymentHigher operational complexity, dual governanceHigh

The right choice depends on your use case, customer environment, and tolerance for operational complexity. Most engineering teams should begin with a narrowly scoped, rules-heavy architecture and then add model assistance where it clearly improves quality or throughput. That progression gives you safety, faster validation, and a cleaner path to scaling across new sites. It also aligns with the broader market reality: in a category growing as quickly as clinical decision support, architectures that are too rigid will not keep pace, but architectures that are too flexible without governance will not survive scrutiny.

Conclusion: Build for Safety, Then Scale for Adoption

Clinical decision support succeeds when engineering choices match clinical realities. FHIR integration, model serving, audit logging, privacy controls, and hybrid deployment patterns are not separate concerns; they are the operating system of a safe CDSS. Teams entering healthtech should resist the temptation to optimize only for model accuracy or deployment speed. The systems that win are the ones that can be explained, reviewed, monitored, and trusted by clinicians and compliance teams alike.

As the market expands, buyers will reward products that ship with strong guardrails, clear evidence, and low-integration friction. That means your architecture must support both rapid iteration and rigorous governance from the start. If you want to compare adjacent operational design patterns, it is worth studying how other teams handle complex CI/CD pipelines, emerging AI-compute tradeoffs, and trust validation workflows in other high-stakes domains. The common thread is the same: safe systems are designed, instrumented, and governed end to end.

FAQ

What is the best architecture for a first CDSS product?

For most teams, the best starting point is a rules-heavy, FHIR-integrated sidecar service with strong audit logging. It is easier to validate, explain, and deploy than a fully autonomous ML system. You can add model-assisted ranking later once the workflow, data quality, and governance are stable.

Do we need FHIR to build clinical decision support?

Not always, but it is the most practical interoperability standard for modern healthtech. If your product must integrate with multiple EHRs, FHIR reduces custom mapping work and improves maintainability. In legacy environments, you may still need HL7 or vendor-specific adapters alongside FHIR.

Should CDSS inference run in the cloud or at the edge?

Cloud is usually best for centralized governance, larger models, and easier scaling. Edge is helpful for offline resilience, low latency, or local autonomy. Many production systems use a hybrid approach so that basic safety checks remain available even when connectivity is limited.

What audit logs are required for clinical decision support?

You should log the patient context used, model or rule version, timestamps, recommendation output, user identity, and the final action taken. The logs should be structured, immutable, and searchable. This creates defensibility for compliance reviews and incident analysis.

How do we prevent alert fatigue?

Start with narrow use cases, tune thresholds carefully, and monitor override rates and acceptance rates. Use clinical feedback loops to suppress low-value alerts and prioritize high-signal recommendations. A good CDSS should reduce noise, not add to it.

How do we know when the system is safe enough to scale?

Look for stable performance in shadow mode, low incident rates, acceptable override behavior, and documented approval from clinical stakeholders. You should also have rollback procedures, versioned validation artifacts, and well-defined ownership before broader rollout. Safety is not a single test; it is a repeatable operational state.

Advertisement

Related Topics

#healthtech#architecture#ai
D

Daniel Mercer

Senior HealthTech Content Strategist

Senior editor and content strategist. Writing about technology, design, and the future of digital media. Follow along for deep dives into the industry's moving parts.

Advertisement
2026-04-16T21:45:37.416Z